Moderna and Merck co-developed an experimental cancer vaccine, while also forming a partnership regarding tensor processing units with Google and Marvell Technology.
2 reports, 2 independent
Updated Aug 19
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Moderna and Merck co-developed an experimental cancer vaccine, while also forming a partnership regarding tensor processing units with Google and Marvell Technology.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Moderna
American biotechnology company
-
Merck
public company in Indonesia
-
Google
American multinational technology company, a subsidiary of Alphabet Inc.
Related events
- Moderna announced a collaboration with Merck KGaA regarding a personalized cancer vaccine platform.
- Moderna and Merck are developing cancer vaccines in partnership, while Moderna is also seeking approval for its seasonal influenza vaccine.
- Moderna and Merck announced a partnership on their mRNA cancer vaccine trial, leading to analyst rating hikes.
- Moderna, Merck, and Georgetown Lombardi Comprehensive Cancer Center are collaborating on developing a personalized cancer vaccine combination.
- Moderna and Merck KGaA are working on personalized melanoma shots, with manufacturing challenges being discussed by Amy Walker.